¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦49Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦9Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 2 : 2023-06-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦49Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦9Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 2 : 2023-06-16
±³À°ÀÏÀÚ : 2023-06-16
±³À°Àå¼Ò : ¼­¿ï·Ôµ¥È£ÅÚ 2,3Ãþ

±³À°ÁÖÁ¦ : Á¦49Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦9Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 2

ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486  

À̸ÞÀÏ : cancer2@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú, ¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ

Âü¼®¿¹»óÀÎ : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 19 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 200,000¿ø  

ºñ°í "1. ȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 10¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 5¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 15¸¸¿ø

2. ºñȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 15¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 7¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 20¸¸¿ø"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 09:00~09:20 Nationwide network of genomic medicine Juergen Wolf(University Hospital Cologne, Germany)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 09:20~09:40 Leveraging genomic data into clinic, -or even clinical trials ¾È¼º±Í(°­³²¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 09:40~10:00 Prescribing genomic analyses in clinic, evidences and practical issues ±è½ÃÇö(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 09:00~09:30 A mechanism of oncogene amplification in breast cancer June-Koo Lee(Memorial Sloan Kettering Cancer Center, USA)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 09:30~09:50 Cancer prevention È«Á¤¿ë(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 09:50~10:10 Unraveling the role of neural stem cells in glioblastoma and targeting tumor-initiating cells to prevent recurrence ÀÌÁÖÈ£(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 09:00~09:20 Molecular pathology of pediatric brain tumors ±è¼¼ÈÆ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 09:20~09:40 Molecular targeted therapy for pediatric brain tumors ÃÖÁ¤À±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 09:40~10:00 Personalized medicine in brain tumors ³²µµÇö(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire B 09:30~10:00 Next-generation approaches to discovering therapeutics and therapeutic targets in cancer William R. Sellers(Broad Institute, USA)

ÈÞ½Ä 06¿ù 16ÀÏ 10:00~10:20 ÈÞ½Ä ()

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 10:20~11:00 Adjuvant treatment of resectable gastric cancer. Where are we now in Asia? °­À±±¸(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 11:00~11:40 Mechanism of action and inflammatory axis for air pollution induced non-small cell lung cancer Charles Swanton(Francis Crick Institute & UCL Cancer Institute, UK)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 11:40~12:20 New approaches for treatment of small cell lung cancer ¾Èº´Ã¶(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 11:40~12:00 IO in GC/GEJ/EAC 1L with 3y long-term data ¹è¿ì±Õ(Àü³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 11:40~12:00 Take hope further for HR+HER2- high-risk early breast cancer patients with abemiciclib À̱ټ®(±¹¸³¾Ï¼¾ÅÍ)

½Ä»ç 06¿ù 16ÀÏ 12:20~13:20 ½Ä»ç ()

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 13:20~13:45 Genomic approaches to identifying neoantigen vaccine and CAR therapy targets ÃÖÁ¤±Õ(KAIST)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 13:45~14:10 Implications of cancer cell state plasticity for therapeutic intervention Wai Leong Tam(CSI Singapore & National University of Singapore, Singapore)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 14:10~14:35 R-loop-induced phase separation instigates the Alternative Lengthening of Telomeres (ALT) upon BRCA2 abrogation ÀÌÇö¼÷(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 14:35~15:00 Widespread upregulation of 3¡¯UTR splicing in cancers Yvonne Tay(CSI Singapore, National University of Singapore, Singapore)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 13:20~13:45 Glioblastoma metabolism and radioresistance À±ºÎÇö(ºÎ»ê´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 13:45~14:10 Ceria-based nanoparticles for therapeutic antioxidants and radioprotectants ÇöÅÃȯ(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 14:10~14:35 Immune-regulatory radiosensitizers ±èÀ缺(Çѱ¹¿øÀÚ·ÂÀÇÇпø)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 14:35~15:00 Novel radiosensitizers Chunlin Shao(Fudan University, China)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 13:20~13:45 Changes in the tumor immune microenvironment during treatment in ovarian cancer ÀÌÁ¤À±(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 13:45~14:10 Immunotherapy related biomarker in gynecologic cancer È«¼÷Èñ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 14:10~14:35 Brachytherapy in cervical cancer ±è¿¬ÁÖ(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 14:35~15:00 Recent update of the radiologic characterization and report of ovarian cancer Ȳ¼ºÀÏ(ºÐ´ç¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire B 13:20~13:45 NOIU ±¹³» Ç×¾Ï½Å¾à °³¹ß Á߿伺 ¹× Àü¸Á ±èÇбÕ(Ç׾Ͻžà½ÅÄ¡·á°³¹ß»ç¾÷´Ü)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire B 13:45~14:10 Next generation PARP and TNKS inhibitor development ±èÁ¸(Onconic)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire B 14:10~14:35 HPV therapeutic vaccine development for the treatment of recurrent/metastatic cervical cancer ¹ÚÁ¾¼·(Genexine)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire B 14:35~15:00 T cell agonist anti-4-BB in the clinical trial ÀÌÁß¿ø(Eutilex)

ÈÞ½Ä 06¿ù 16ÀÏ 15:00~15:20 ÈÞ½Ä ()

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 15:20~15:45 Design and interpretation of (Neo)adjuvant trials Á¶ÁÖÈñ(¼º±Õ°ü´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 15:45~16:10 Pathologic assessments after neoadjuvant treatments °ø°æ¿±(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 16:10~16:35 Pathologic complete response as an endpoint in clinical trials ±èÁöÇö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal A 16:35~17:00 Neoadjuvant vs. adjuvant chemoimmunotherapy °­ÀºÁÖ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 15:20~15:45 Analyzing method for spatial biology Quan Nguyen(The University of Queensland, Australia)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 15:45~16:10 New method for data genration of spatial biology (proteomics/multiomics) ±Ç¼ºÈÆ(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 16:10~16:35 Immune checkpoint inhibitors in gastric cancer Tae Hyun Hwang(Mayo Clinic, USA)

±³À°½Ã°£ 06¿ù 16ÀÏ Crystal B 16:35~17:00 Spatial transcriptomics for clinical translation ³ª±ÇÁß(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 15:20~15:45 MDT management of HCC Dandan Hu(Sun Yat-Sen University Cancer Center, China)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 15:45~16:10 Recent progress for early detection of HCC in chronic liver diseases ¼ºÇʼö(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 16:10~16:35 Emerging neoadjuvant or conversion therapies Tianqiang Song(Tianjin Medical University Cancer Institute & Hospital, China)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire A 16:35~17:00 Could we predict the response of immune checkpoint inhibitor treatment in hepatocellular carcinoma? ÀüÈ«Àç(Â÷ÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire B 15:20~15:45 ¾ÏÁ¤¹ÐÀÇÇп¡¼­ NGS ÀÓ»ó Àû¿ëÀÇ ±Û·Î¹ú ÇöȲ À±½Å±³(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire B 15:45~16:10 ¾Ï Áø´Ü ¹× Ä¡·á °úÁ¤¿¡¼­ À¯Àüü ÇÁ·ÎÆÄÀϸµÀÇ ¿ªÇÒ ¹× ¹Ì·¡ (ÀǾà¾÷°è Àü¸Á) ±è½ÂÀº(³ë¹ÙƼ½º)

±³À°½Ã°£ 06¿ù 16ÀÏ Sapphire B 16:10~16:35 ±¹³» NGS ±â¹Ý ¾ÏÁ¤¹ÐÀÇ·á ¿¬±¸ Ç÷§Æû - KOSMOS II ±è¼±¿µ(¼­¿ï¾Æ»êº´¿ø)

Åä·Ð 06¿ù 16ÀÏ Sapphire B 16:35~17:00 Q&A Discussion ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦49Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦9Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 2 : 2023-06-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø ¼øȯ±â³»°ú Á¦2ȸ SMC Æó°íÇ÷¾Ð ½ÉÆ÷Áö¾ö : 2023-06-16
´ÙÀ½±Û ´ëÇÑû¼Ò³âÁ¤½ÅÀÇÇÐȸ All about ADHD in adolescence and early adulthood" : 2023-06-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20988 ¼­¿ï 2024 Á¦ 13ȸ ´ëÇѺñ´¢»ý½Ä±âÅëÇÕ±â´ÉÀÇÇבּ¸È¸ Çмú´ëȸ : 2024-06-22 0 11 2024-06-14
20987 Ãæ³² 2024³â ´ëÇÑ°í°üÀýÇÐȸ Áø·áÁöħ ½ÉÆ÷Áö¿ò : 2024-06-22 0 10 2024-06-14
20986 ±¤ÁÖ Á¦24ȸ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ È£³²Áöȸ Á¤±âÇмú´ëȸ : 2024-06-22 0 15 2024-06-14
20985 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(2ÀÏÂ÷) : 2024-06-22 0 9 2024-06-14
20984 °æºÏ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦43Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-22 0 8 2024-06-14
20983 °æ³² 2024 ÁøÁÖ½ÃÀÇ»çȸ »ó¹Ý±â Àǻ翬¼ö±³À° : 2024-06-22 0 4 2024-06-14
20982 °æ±â °¡Å縯´ëÇб³ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¦ 8Â÷ °æ±âºÏºÎ °³¿øÀǸ¦ À§ÇÑ Çмú´ëȸ : 2024-06-22 0 5 2024-06-14
20981 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-22 0 7 2024-06-14
20980 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ 11ȸ °ø¿¬¹ß¼º ½ÉÆ÷Áö¾ö : 2024-06-22 0 5 2024-06-14
20979 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22 0 5 2024-06-14
20978 ÀüºÏ Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22 0 5 2024-06-14
20977 Á¦ÁÖ ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22 0 4 2024-06-14
20976 ±¤ÁÖ 2024³â »ó¹Ý±â ±¤ÁÖ±¤¿ª½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 12 2024-06-14
20975 ¼­¿ï 2024³â ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-21 0 4 2024-06-14
20974 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 SNUH Rare Disease Workshop : 2024-06-21 0 3 2024-06-14
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷